Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Semaglutide is a synthetic GLP-1 receptor agonist
Its higher dosage (2.4mg/week) is specifically designed to produce greater appetite suppression and metabolic support
Pharmacological progress in metabolic research models: tirzepatide's rising advantage [PMID: 41497097] Laboratory literature summary: Pharmacological progress in metabolic research models: tirzepatide's rising advantage over semaglutide
For a deeper look at what GLP-1 medications can do to your digestion (and how to manage it), check out our guide on common side effects of Ozempic and Mounjaro
Kidney Int (2014) 85(3):57989
US$ 28.85
US$ 21.15
US$ 23.26
US$ 21.03
US$ 20.52
US$ 24.80
US$ 27.35
US$ 22.05
